Prophylactic Administration of Recombinant Human Thrombopoietin in the Secondary Prevention of Thrombocytopenia Induced by XELOX Adjuvant Chemotherapy in Patients With Stage III Colorectal Cancer

被引：3
|
作者：
Jin, Gaowa [1 ]
Wu, Yahan [2 ]
She, Zhanfei [3 ]
Ma, Xiaoyun [4 ]
Deng, Shuqin [1 ]
Wang, Wenjuan [1 ]
Wu, Yungaowa [1 ]
Li, Quanfu [1 ]
机构：
[1] Ordos Cent Hosp, Dept Med Oncol, Ordos, Peoples R China
[2] Peoples Hosp Inner Mongolia Autonomous Region, Dept Med Oncol, Hohhot, Peoples R China
[3] Ordos Cent Hosp, Dept Abdominal Surg, Ordos, Peoples R China
[4] Chifeng Cent Hosp, Dept Med Oncol, Chifeng, Peoples R China
来源：
AMERICAN JOURNAL OF THERAPEUTICS | 2021年 / 28卷 / 04期
关键词：
OXALIPLATIN;
D O I：
10.1097/MJT.0000000000001331
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：E513 / E516
页数：4
相关论文
共 50 条
  • [1] Prophylactic Administration of Recombinant Human Thrombopoietin in the Secondary Prevention of Thrombocytopenia Induced by XELOX Adjuvant Chemotherapy in Patients With Stage III Colorectal Cancer (vol 28, pg e513, 2021)
    Jin, G.
    Wu, Y.
    She, Z.
    AMERICAN JOURNAL OF THERAPEUTICS, 2021, 28 (06) : E813 - E813
  • [2] THE APPLICATION OF RECOMBINANT HUMAN THROMBOPOIETIN (RHTPO) IN SECONDARY PREVENTION OF CHEMOTHERAPY INDUCED THROMBOCYTOPENIA PATIENTS IN CHINA
    Yang, F.
    Li, L.
    Xuan, J.
    VALUE IN HEALTH, 2017, 20 (05) : A315 - A315
  • [3] Prophylactic administration of recombinant human thrombopoietin attenuates XELOX or SOX regimen-induced thrombocytopaenia
    Li, Quanfu
    Jin, Gaowa
    Jiang, Caihong
    Zhang, Zewei
    Hou, Jixiang
    Zhao, Juan
    Chen, Feng
    Li, Zhenhao
    ARCHIVES OF MEDICAL SCIENCE, 2021, 17 (05) : 1440 - 1446
  • [4] The efficacy of XELOX and FOLFOX adjuvant chemotherapy in stage III colorectal cancer patients with low preoperative serum albumin levels
    Chen, Po-Ming
    Lin, Chun-Yi
    Chen, Rong-Fu
    Chen, Yeh-Ku
    Chu, Pei-Yi
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (02): : 3162 - 3168
  • [5] Clinical observation study of recombinant human thrombopoietin in the prevention of chemotherapy-induced thrombocytopenia in patients with aggressive lymphoma.
    Yang, Lei
    Wang, Ting
    Li, Zhenling
    Deng, Qi
    Yang, Wei
    Zhou, Hebing
    Jing, Hongmei
    Sun, Changyong
    Wang, Liru
    Bao, Li
    Ye, Fang
    Bai, Jie
    Si, Lu
    Wang, Jingwen
    Liu, Hui
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Clinical experience with recombinant human thrombopoietin in chemotherapy-induced thrombocytopenia
    Vadhan-Raj, S
    SEMINARS IN HEMATOLOGY, 2000, 37 (02) : 28 - 34
  • [7] Is there alternative to FOLFOX adjuvant chemotherapy for stage III colorectal cancer patients?
    Esch, Anouk
    Coriat, Romain
    Perkins, Geraldine
    Brezault, Catherine
    Chaussade, Stanislas
    PRESSE MEDICALE, 2012, 41 (01): : 51 - 57
  • [8] Adjuvant chemotherapy for stage III colorectal cancer in the elderly
    Brungs, D.
    Healey, E.
    Rose, J.
    Tubaro, T.
    Ng, W.
    Chua, W.
    Carolan, M.
    de Souza, P.
    Aghmesheh, M.
    Ranson, M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [9] SAFETY AND TOLERABILITY OF ADJUVANT OXALOPLATIN/CAPECITABINE (XELOX) CHEMOTHERAPY IN STAGE III COLORECTAL CANCER - SINGLE CENTRE REVIEW
    Gyi, M.
    O'Callaghan, A.
    Muthuramalingam, S.
    ANNALS OF ONCOLOGY, 2010, 21 : 113 - 113
  • [10] Hetrombopag plus recombinant human thrombopoietin for chemotherapy-induced thrombocytopenia in patients with solid tumors
    Xia, Xiaohui
    Zhou, Haiting
    Zhang, Hao
    Deng, Wanjun
    Li, Rui
    Huang, Qiao
    Wang, Yuehua
    Xiong, Huihua
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2023, 7 (07)
12345